Alira Health
Alira Health Secures Up to $100M Growth Debt Facility from Symbiotic Capital to Propel Strategic Expansion and Patient-Enabled Innovation
Alira Health Secures Up to $100M Growth Debt Facility from Symbiotic Capital to Propel Strategic Expansion and Patient-Enabled Innovation
FRAMINGHAM, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Alira Health, a global healthcare consulting and technology firm transforming the patient journey, announced today the securing of up to $100 million in growth debt from Symbiotic Capital, a premier healthcare and life sciences investor. This funding will drive Alira Health’s strategic growth, enhance its innovative technology platforms, and support solutions that empower patients and create value for life sciences companies.
“This significant investment from Symbiotic Capital validates our vision for patient-centered healthcare,” said Gabriele Brambilla, Co-CEO of Alira Health. “The funding will enable us to accelerate patient-enabled innovation, scale our integrated solutions, and strengthen the technology platforms that serve both patients and life sciences companies.”
To facilitate this expansion, Alira Health has established a Chief Operating Officer (COO) role, appointing Andrea Pulvirenti, a seasoned company leader, to oversee operations and manage the scaling of its global presence.
“We’re excited to partner with Alira Health as they redefine the biopharma and medtech research landscape,” said Himani Bhalla, Chief Investment Officer and Co-Founder of Symbiotic Capital. “Their patient-first approach and integrated solutions are advancing the life sciences ecosystem and improving patient outcomes.”
For more information about Alira Health, visit www.alirahealth.com.
About Alira Health
Alira Health is a global healthcare consulting and technology firm dedicated to advancing the life sciences ecosystem. By integrating evidence-based insights with cutting-edge technology, Alira Health empowers clients in pharma, medtech, and biotech to improve patient outcomes. Learn more at www.alirahealth.com.
About Symbiotic Capital
Symbiotic Capital is a healthcare credit firm that brings together decades of experience across life sciences, finance, and entrepreneurship. Symbiotic Capital's integration into a global ecosystem empowers it to provide lending solutions to fuel the growth of established healthcare companies around the world.
For more information, please visit www.symbcap.com.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Financière de Tubize SA2.8.2025 08:00:00 CEST | Press release
Financière de Tubize - 2025 half-year financial report
DBV Technologies S.A.1.8.2025 22:05:00 CEST | Press release
Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2025
Mandalay Resources Corporation1.8.2025 21:12:01 CEST | Press release
Mandalay Obtains Final Order Approving Arrangement with Alkane
F. Hoffmann-La Roche Ltd1.8.2025 20:00:00 CEST | Press release
Roche’s Susvimo maintains vision over five years with two refills per year in people with neovascular age-related macular degeneration (nAMD)
KBC Groep1.8.2025 18:10:00 CEST | Press release
KBC Group: KBC remains well-capitalised under 2025 EU-wide EBA stress test
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom